Back

Genomic network analysis links uveitis with systemic inflammatory diseases

Chau, K.; Allison, K.; Braithwaite, T.; Harley, I.; Hassman, L. M.

2026-03-26 ophthalmology
10.64898/2026.03.24.26349228 medRxiv
Show abstract

ObjectiveTo determine whether uveitis shares genetic similarity with extraocular immune-mediated inflammatory diseases (IMIDs), we performed network analysis of putative causal genes associated with ocular inflammatory disease, IMIDs and eye-specific diseases, including age-related macular degeneration and monogenic disorders. MethodsWe identified putative causal genes for genome-wide significance variants from uveitis, IMIDs and ocular diseases using OpenTargets and published studies. To assess the gene-level pleiotropy between disease groups, we quantified the causal gene overlap between groups, and the Jaccard Similarity Indices for individual disease pairs. We then used a network approach to assess the molecular genetic similarity between diseases at a biological pathway level and comparative statistics to identify diseases with greater network similarity to uveitis. ResultsSeventy-five percent of the putative causal genes for uveitis are also causal for IMIDs, while no uveitis genes are shared with primary ocular disorders. Network analysis revealed that 1) uveitis genes are more closely networked with systemic IMIDs disease genes than with ocular-specific disease genes; and 2) significant network similarity links uveitis and specific IMIDs, such as ankylosing spondylitis and sarcoidosis. ConclusionsOverlapping causal genes and network similarity indicate that uveitis is predominantly an inflammatory disease, sharing genetic architecture with other IMIDs. Future studies aimed at dissecting genetic heterogeneity within uveitis may determine whether subgroups share common immune pathways that could nominate endotype-specific therapeutic approaches.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Eye
11 papers in training set
Top 0.1%
14.5%
2
PLOS ONE
4510 papers in training set
Top 15%
12.5%
3
Scientific Reports
3102 papers in training set
Top 18%
6.4%
4
Journal of Allergy and Clinical Immunology
25 papers in training set
Top 0.2%
4.0%
5
BMC Medical Genomics
36 papers in training set
Top 0.1%
3.7%
6
Experimental Eye Research
30 papers in training set
Top 0.2%
3.6%
7
Ophthalmology Science
20 papers in training set
Top 0.1%
3.6%
8
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.2%
3.6%
50% of probability mass above
9
Vaccines
196 papers in training set
Top 0.7%
3.3%
10
Annals of the Rheumatic Diseases
32 papers in training set
Top 0.3%
2.8%
11
Orphanet Journal of Rare Diseases
18 papers in training set
Top 0.2%
2.6%
12
Annals of Translational Medicine
17 papers in training set
Top 0.7%
1.7%
13
British Journal of Ophthalmology
14 papers in training set
Top 0.2%
1.7%
14
F1000Research
79 papers in training set
Top 2%
1.7%
15
Arthritis & Rheumatology
33 papers in training set
Top 0.3%
1.7%
16
BMC Genomics
328 papers in training set
Top 3%
1.3%
17
Rheumatology
21 papers in training set
Top 0.3%
1.3%
18
European Respiratory Journal
54 papers in training set
Top 1%
1.2%
19
Nature Communications
4913 papers in training set
Top 56%
1.2%
20
Clinical Chemistry and Laboratory Medicine (CCLM)
12 papers in training set
Top 0.2%
0.9%
21
Multiple Sclerosis Journal
18 papers in training set
Top 0.2%
0.9%
22
Human Molecular Genetics
130 papers in training set
Top 3%
0.9%
23
JCI Insight
241 papers in training set
Top 6%
0.9%
24
Frontiers in Endocrinology
53 papers in training set
Top 2%
0.9%
25
Clinical Infectious Diseases
231 papers in training set
Top 4%
0.9%
26
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 41%
0.9%
27
International Journal of Environmental Research and Public Health
124 papers in training set
Top 6%
0.8%
28
JMIR Formative Research
32 papers in training set
Top 1%
0.8%
29
Respiratory Research
19 papers in training set
Top 0.4%
0.8%
30
Journal of Medical Internet Research
85 papers in training set
Top 4%
0.8%